[go: up one dir, main page]

NO990706D0 - Behandling av allergiske responser i °vre luftveier med en kombinasjon av histaminreseptorantagonister - Google Patents

Behandling av allergiske responser i °vre luftveier med en kombinasjon av histaminreseptorantagonister

Info

Publication number
NO990706D0
NO990706D0 NO990706A NO990706A NO990706D0 NO 990706 D0 NO990706 D0 NO 990706D0 NO 990706 A NO990706 A NO 990706A NO 990706 A NO990706 A NO 990706A NO 990706 D0 NO990706 D0 NO 990706D0
Authority
NO
Norway
Prior art keywords
treatment
combination
receptor antagonists
respiratory tract
histamine receptor
Prior art date
Application number
NO990706A
Other languages
English (en)
Other versions
NO990706L (no
Inventor
William Kreutner
John A Hey
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of NO990706D0 publication Critical patent/NO990706D0/no
Publication of NO990706L publication Critical patent/NO990706L/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/02Nasal agents, e.g. decongestants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/16Otologicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
NO990706A 1996-08-16 1999-02-15 Behandling av allergiske responser i °vre luftveier med en kombinasjon av histaminreseptorantagonister NO990706L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US68995196A 1996-08-16 1996-08-16
PCT/US1997/013903 WO1998006394A1 (en) 1996-08-16 1997-08-13 Treatment of upper airway allergic responses with a combination of histamine receptor antagonists

Publications (2)

Publication Number Publication Date
NO990706D0 true NO990706D0 (no) 1999-02-15
NO990706L NO990706L (no) 1999-02-15

Family

ID=24770500

Family Applications (1)

Application Number Title Priority Date Filing Date
NO990706A NO990706L (no) 1996-08-16 1999-02-15 Behandling av allergiske responser i °vre luftveier med en kombinasjon av histaminreseptorantagonister

Country Status (25)

Country Link
EP (1) EP0920315B1 (no)
JP (2) JP3638289B2 (no)
KR (1) KR20000029975A (no)
CN (1) CN1152682C (no)
AR (1) AR008293A1 (no)
AT (1) ATE314071T1 (no)
AU (1) AU722040B2 (no)
BR (1) BR9711149A (no)
CA (1) CA2263163A1 (no)
CO (1) CO4910138A1 (no)
CZ (1) CZ43299A3 (no)
DE (1) DE69734984D1 (no)
HU (1) HUP9904362A3 (no)
ID (1) ID17871A (no)
IL (1) IL128573A0 (no)
MY (1) MY116130A (no)
NO (1) NO990706L (no)
NZ (1) NZ334063A (no)
PE (1) PE100298A1 (no)
PL (1) PL191073B1 (no)
SK (1) SK20099A3 (no)
TR (1) TR199900326T2 (no)
TW (2) TWI221768B (no)
WO (1) WO1998006394A1 (no)
ZA (1) ZA977263B (no)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2284705A1 (en) * 1997-03-26 1998-10-01 Sepracor Inc. Chemically and thermally stable norastemizole formulations
PT998272E (pt) * 1997-08-26 2003-09-30 Aventis Pharma Inc Composicao farmaceutica para combinacao do descongestionante piperidinoalcanol
JP2001522835A (ja) * 1997-11-07 2001-11-20 シェーリング コーポレイション フェニル−アルキル−イミダゾール型のh3レセプターリガンド
US5990147A (en) * 1997-11-07 1999-11-23 Schering Corporation H3 receptor ligands of the phenyl-alkyl-imidazoles type
US6034251A (en) * 1997-11-07 2000-03-07 Schering Corporation Phenyl-alkyl-imidazoles
HUP0102662A3 (en) * 1997-11-07 2003-01-28 Schering Corp Imidazoylalkyl substituted with a five, six or seven membered heterocyclic ring containing one nitrogen atom
JP2001522836A (ja) * 1997-11-07 2001-11-20 シェーリング コーポレイション H3レセプターアンタゴニストとしてのフェニル−アルキル−イミダゾール
US6384038B1 (en) * 1998-04-14 2002-05-07 Sepracor Inc. Methods and compositions using cetirizine in combination with leukotriene inhibitors or decongestants
JP2002527381A (ja) * 1998-10-09 2002-08-27 シェーリング コーポレイション アレルギー性疾患を処置するための組成物および方法
US6100279A (en) * 1998-11-05 2000-08-08 Schering Corporation Imidazoylalkyl substituted with a five, six or seven membered heterocyclic ring containing one nitrogen atom
AU7589700A (en) * 1999-09-22 2001-04-24 Schering Corporation Treating allergic and inflammatory conditions
JP2003521515A (ja) * 2000-02-03 2003-07-15 シェーリング コーポレイション アレルギー状態および炎症状態の処置
PE20020507A1 (es) 2000-10-17 2002-06-25 Schering Corp Compuestos no-imidazoles como antagonistas del receptor histamina h3
GB2373186A (en) * 2001-02-23 2002-09-18 Astrazeneca Ab Pharmaceutical combinations of a CCR3 antagonist and a compound which is usefulreatment of asthma, allergic disease or inflammation
CN1298715C (zh) 2001-03-13 2007-02-07 先灵公司 作为组胺h3拮抗剂的非咪唑化合物
PE20040464A1 (es) 2002-04-18 2004-07-24 Schering Corp Benzimidazolonas sustituidas y derivados como antagonistas de histamina h3
US7105505B2 (en) 2002-04-18 2006-09-12 Schering Corporation Benzimidazole derivatives useful as histamine H3 antagonists
PT1539742E (pt) 2002-06-24 2007-01-31 Schering Corp Derivados de índole úteis como antagonistas h3 de histamina
WO2004066960A2 (en) * 2003-01-28 2004-08-12 Schering Corporation Combination of h1, h3 and h4 receptor antagonists for treatment of allergic and non-allergic pulmonary inflammation, congestion and allergic rhinitis
EP1902046B1 (en) 2005-06-20 2009-12-02 Schering Corporation Piperidine derivatives useful as histamine h3 antagonists
WO2010027567A2 (en) 2008-07-23 2010-03-11 Schering Corporation Tricyclic spirocycle derivatives and methods of use thereof
EP2350048A2 (en) 2008-10-16 2011-08-03 Schering Corporation Azine derivatives and methods of use thereof
EP2379565A1 (en) 2008-12-19 2011-10-26 Schering Corporation Piperidine and piperazine derivatives and methods of use thereof
US8283360B2 (en) 2008-12-19 2012-10-09 Merck Sharp & Dohme Corp. Bicyclic heterocyclic derivatives and methods of use thereof
US8569273B2 (en) 2009-03-17 2013-10-29 Aciex Therapeutics, Inc. Ophthalmic formulations of cetirizine and methods of use
ES2910374T3 (es) 2009-03-17 2022-05-12 Nicox Ophthalmics Inc Formulaciones oftálmicas de cetirizina y procedimientos de uso
CN107582551A (zh) * 2009-05-14 2018-01-16 总医院公司 治疗退化性及缺血性疾病的方法和组合物
US8759357B2 (en) 2009-10-08 2014-06-24 Merck Sharp & Dohme Corp. Inhibitors of fatty acid binding protein (FABP)
WO2013151982A1 (en) 2012-04-03 2013-10-10 Arena Pharmaceuticals, Inc. Methods and compounds useful in treating pruritus, and methods for identifying such compounds
RU2685277C1 (ru) * 2018-05-24 2019-04-17 Общество с ограниченной ответственностью "Фарминтерпрайсез Аллерджи" Применение бисамидного производного малоновой кислоты для лечения аллергических и других заболеваний человека и животных

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU201683B (en) * 1987-08-04 1990-12-28 Biogal Gyogyszergyar Process for producing pharmaceutical compositions for promoting healing of wounds
US5019591A (en) * 1989-02-17 1991-05-28 Pennsylvania Research Corporation Method for treating retinopathy and other small vessel disorders associated with diabetes
GB9303210D0 (en) * 1993-02-17 1993-03-31 Univ Manitoba Cancer treatment

Also Published As

Publication number Publication date
CN1233179A (zh) 1999-10-27
CN1152682C (zh) 2004-06-09
MY116130A (en) 2003-11-28
NZ334063A (en) 2000-09-29
TWI221768B (en) 2004-10-11
JP2003095979A (ja) 2003-04-03
PE100298A1 (es) 1999-01-11
ATE314071T1 (de) 2006-01-15
CO4910138A1 (es) 2000-04-24
EP0920315B1 (en) 2005-12-28
NO990706L (no) 1999-02-15
WO1998006394A1 (en) 1998-02-19
HUP9904362A2 (hu) 2000-11-28
BR9711149A (pt) 1999-08-17
ID17871A (id) 1998-02-05
PL331617A1 (en) 1999-08-02
HUP9904362A3 (en) 2000-12-28
IL128573A0 (en) 2000-01-31
AU722040B2 (en) 2000-07-20
AR008293A1 (es) 1999-12-29
CA2263163A1 (en) 1998-02-19
AU3973397A (en) 1998-03-06
KR20000029975A (ko) 2000-05-25
EP0920315A1 (en) 1999-06-09
CZ43299A3 (cs) 1999-07-14
JP2000505094A (ja) 2000-04-25
ZA977263B (en) 1998-02-16
JP3638289B2 (ja) 2005-04-13
PL191073B1 (pl) 2006-03-31
SK20099A3 (en) 2000-08-14
TW200427450A (en) 2004-12-16
DE69734984D1 (de) 2006-02-02
TR199900326T2 (xx) 1999-05-21

Similar Documents

Publication Publication Date Title
NO990706D0 (no) Behandling av allergiske responser i °vre luftveier med en kombinasjon av histaminreseptorantagonister
FI20002103L (fi) Amidijohdannaisia ja nosiseptiiniantagonisteja
PT832082E (pt) Derivados de n-heteroaril-piridinossulfonamidas e sua utilizacao como antagonistas de endotelina
CY2015056I1 (el) Ανασυνδυασμενοι antαγωνιστες της il-5 που ειναι χρησιμοι στη θεραπεια διαταραχων που διαμεσολαβουνται απο την il-5
FI973446A7 (fi) Bentsyylipiperidiinit ja piperatsiinit muskariiniantagonisteina
FI946005L (fi) Glysiinireseptoriantagonisteja ja niiden käyttö
DE69932265D1 (de) Musikaktionsspielsystem und computerlesbare Aufzeichnungsvorrichtung
DE69515891T8 (de) Verbundstoff und saugfähiges Kleidungsstück mit diesem Verbundstoff
FI973419L (fi) Epäorgaanisten aerogeelien käyttö lääkkeiden valmistuksessa
IS5113A (is) Notkun antagónista CB1-viðtaka til meðhöndlunar löngunartruflana
EE200000778A (et) 4-bensüülpiperidiinalküülsulfoksiidi heterotsüklid ja nende kasutamine NMDA retseptori alaliikide suhtes selektiivsete antagonistidena
FI961270A7 (fi) Takykiniinien antagonisteja ja 3-(5-tetratsolyyli-bentsyyli)amino-piperidiinijohdannaisia
DE60019844D1 (de) Implantierbare medizinische Vorrichtung mit Kondensatoranordnung und Isolierschicht
DE69622148D1 (de) Chinazozin derivate und deren verwendung
EE04431B1 (et) Bensamidiini derivaadid ja nende kasutamine LTB-4antagonistliku mõjuga ravimitena
DE69230654D1 (de) Commiphora-Mukul-Extrakte und deren therapeutische Verwendung
DE69903961D1 (de) Muscarinagonisten und antagonisten
NO994321D0 (no) Absorberende gjenstand med "pustende" ytre lag
FI932573A7 (fi) Ihmisen dopamiini-D4-reseptori ja sen käyttöjä
PT946175E (pt) Utilizacao de uma combinacao de inibidores de h+, k+ -atpase e de glucocorticiodes no tratamento de polipos nasais
NO983871D0 (no) Oksa- og tiadiazol muskarinreseptorantagonister
IL131127A0 (en) 2-Amino substituted pyridines for use in the treatment of arteriosclerosis and hyperlipoproteinaemia
NO962806D0 (no) Absorberende gjenstand med innböyde barrieremansjetter
EP0747055A3 (en) Use of tachykinin receptor antagonists to treat the common cold and allergic rhinitis
DE69427921D1 (de) Epsilon opioid rezeptor und dessen verwendungen